Larry McGrath
Executive Vice President of Capital Markets
Replay available
CVS Health Corporation (NYSE: CVS) Q4 2025 earnings conference call, held 2026-02-10. Replay captured from the company's public earnings webcast.

Executive Vice President of Capital Markets
Chair and Chief Executive Officer
Chief Financial Officer
President, Aetna
President, Healthcare Delivery (Oak Street Health)
President, CVS Caremark
President, CVS Pharmacy
Analyst, Wolfe Research
Analyst, J.P. Morgan
Analyst, Leerink Partners
Analyst, Barclays
Analyst, Evercore
Analyst, Deutsche Bank
Analyst, Morgan Stanley
Analyst, Mizuho
Hello and welcome to CVS Health's fourth quarter 2025 earnings call. We ask that you please hold all questions until the end of the prepared remarks, at which time you will be given instructions for the question and answer session. As a reminder, this conference is being recorded today. If you have any objections, please disconnect at this time. I would now like to pass the call to Larry McGrath, Chief Strategy Officer. Larry, please proceed. Good morning and welcome to the CVS Health fourth quarter 2025 earnings call and webcast. I'm Larry McGrath, Executive Vice President of Capital Markets at CVS Health. I'm joined this morning by David Joyner, Chair and Chief Executive Officer, and Brian Newman, Chief Financial Officer. Following our prepared remarks, we'll host a question and answer session that will include additional members of the leadership team. Our press release and slide presentation have been posted to our website, along with our Form 10-K filed this morning with the SEC. Today's call has also been broadcast on our website. During this call, we'll make certain forward-looking statements. Our forward-looking statements are subject to significant risks and uncertainties that could cause actual results to differ materially from currently projected results. We strongly encourage you to review the reports we file with the SEC regarding these risks and uncertainties. In particular, those that are described in the cautionary statement concerning forward-looking statements and risk factors in our recent SEC filings, including in our annual report on Form 10-K. During this call, we'll use certain non-GAP measures, and you can find a reconciliation of these non-GAP measures in this morning's press release and in the reconciliation document posted to the investor r...